Company: BDRX
Filing Date: 2025-05-12
Form Type: 424B3
Source: 0001214659-25-007342
Chunk: 15

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-12
Form: 424B3
Chunk 15
---
 Purchase Agreement (assuming the shares are issued at a price of $1.00 per share). To date, we have sold
1,586,451 Purchase Shares and 153,349 Commitment Shares to the Selling Stockholder under the Purchase Agreement.

The Selling Shareholder is
not obligated to buy any Depositary Shares under the Purchase Agreement if such shares, when aggregated with all other securities then
beneficially owned by the Selling Shareholder and its respective affiliates (as calculated pursuant to Section 13(d) of the Exchange Act
and Rule 13d-3 promulgated thereunder), would result in the Selling Shareholder beneficially owning Ordinary Shares in excess of the Beneficial
Ownership Limitation. Our inability to access a portion or the full amount available under the Purchase Agreement, in the absence of any
other financing sources, could have a material adverse effect on our business or results of operation.

The Purchase Agreement and
Registration Rights Agreement contain customary registration rights, representations, warranties, conditions and indemnification obligations
by each party. The representations, warranties and covenants contained in such agreements were made only for purposes of such agreements
and as of specific dates, were solely for the benefit of the parties to such agreements and are subject to certain important limitations.

Purchase Agreement

Pursuant to the Purchase Agreement,
the Selling Shareholder shall, subject to the restrictions and satisfaction of the conditions in the Purchase Agreement, purchase from
us up to $35.0 million of Depositary Shares, upon the terms and subject to the conditions and limitations set forth in the Purchase Agreement,
and, accordingly, we have registered 350,000,000,000 Ordinary Shares representing 35,000,000 Depositary Shares for issuance under the
Purchase Agreement and resale pursuant to this prospectus, assuming that $35.0 million of shares are issued and sold at a price of $1.00
per share. The Depositary Shares that may be issued under the Purchase Agreement may be sold, subject to the restrictions and satisfaction
of the conditions in the Purchase Agreement, by us to the Selling Shareholder at our discretion from time to time from the Commencement
Date until the earliest to occur of a Termination Event.

Purchases of Depositary Shares Under the Purchase Agreement

During the term described
above, on any business day on which the closing sale price of the Depositary Shares is equal to or greater than $1.00, we will have the
right, but not the obligation, from time to time